LABA/LAMA combination inhalers (COPD only)
Choice Drug Dosage Formulary Choices Anoro Ellipta ®▼ DPI
55/22
(umeclidinium /vilanterol)
Dose:
One inhalation daily Or Duaklir Genuair ® DPI 340/12(aclidinium/formoterol)
Dose:
One inhalation twice daily Or Spiolto Respimat® 2.5/2.5 inhalation solution (tiotropium/olodaterol)
Dose:
Two inhalations once daily Or Ultibro Breezhaler®▼ 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium)
Dose:
One inhalation daily
| Choice | Drug | Dosage |
|---|---|---|
| Formulary Choices | Anoro Ellipta ®▼ DPI | Dose: One inhalation daily |
| Or | ||
Duaklir Genuair ® DPI 340/12(aclidinium/formoterol) | Dose: One inhalation twice daily | |
| Or | ||
Spiolto Respimat® 2.5/2.5 inhalation solution (tiotropium/olodaterol) | Dose: Two inhalations once daily | |
| Or | ||
Ultibro Breezhaler®▼ 85/43 inhalation powder capsules with device (indacaterol/glycopyrronium) | Dose: One inhalation daily |
Prescribing Notes
- Consider a LAMA/LABA combination in patients with severe breathlessness symptoms and low risk of exacerbations before considering addition of ICS.
- All LABA/LAMA combination inhalers are less costly than the combined costs of the single inhalers and may be more convenient for patients.